Speaker Profile
Biography
Dr. Megan Levings is an internationally recognized leader in engineering immune tolerance. A pioneer in human regulatory T cell (Treg) biology, she helped establish that these cells can be isolated and expanded for therapeutic use. Her research combines immunology, gene editing and synthetic biology to develop precision cell therapies that restore immune tolerance in transplantation and autoimmune disease. Her team’s advances in chimeric antigen receptor (CAR) Tregs have supported clinical translation of antigen-specific immune regulation. She also leads efforts to develop manufacturing infrastructure for advanced cell and gene therapies and promotes international collaboration in translational immunology. Her contributions have been recognized with numerous awards, including the Canadian Society for Immunology’s Cinader Award and election as a Fellow of the Royal Society of Canada in 2026.
Session Abstract – PMWC 2027 Silicon Valley
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
Day 1 / Wed · Jan 27
Day 2 / Thu · Jan 28
Day 3 / Fri · Jan 29
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
